Trials / Completed
CompletedNCT00643136
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures
Pregabalin BID Add-on Trial: a Randomized, Double-Blind, Placebo-Controlled Parallel-Group Single-Center Sleep EEG Study in Patients With Partial Seizures and Sleep Disturbance Part B: a Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study of Pregabalin Add-on Treatment
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effects of pregabalin on sleep problems in patients with seizures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | Pregabalin capsules 75 mg twice daily on Days 1-4, then 150 mg twice daily on Days 5-28 |
| DRUG | Placebo | Matching placebo capsules twice daily for 28 days |
Timeline
- Start date
- 2002-11-01
- Completion
- 2004-06-01
- First posted
- 2008-03-26
- Last updated
- 2008-04-24
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00643136. Inclusion in this directory is not an endorsement.